Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer

Lung cancer is the second most common cancer and the leading cause of cancer-related deaths. Despite recent advances in the development of targeted therapies, patients with advanced disease remain incurable, mostly because metastatic non-small cell lung carcinomas (NSCLC) eventually become resistant...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Gordian, Edna, Li, Jiannong, Pevzner, Yuri, Mediavilla-Varela, Melanie, Luddy, Kimberly, Ohaegbulam, Kim, Daniel, Kenyon G., Haura, Eric B., Muñoz-Antonia, Teresita
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2014
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4263601/
https://ncbi.nlm.nih.gov/pubmed/25501935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0114131
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk